Financial Results - Standalone (₹ in Lakhs)

Quarter Ended June 30, 2026:

  • Revenue from Operations: ₹1,025.90
  • Total Income: ₹1,025.90
  • Total Expenses: ₹1,151.62
  • Loss Before Tax: ₹(125.72)
  • Tax Expense: ₹(18.22) [Deferred Tax Asset]
  • Loss for the Period: ₹(107.50)
  • Other Comprehensive Income: ₹2.67
  • Total Comprehensive Income: ₹(104.83)
  • Paid-up Equity Share Capital: ₹590.04 (Face value ₹10 each)

Comparative Figures:

  • Q1 FY26 (June 30, 2025): Loss of ₹(96.37)
  • Q4 FY26 (March 31, 2026): Loss of ₹(27.20)
  • Full Year FY26: Loss of ₹(171.98)

Financial Results - Consolidated (₹ in Lakhs)

Quarter Ended June 30, 2026:

  • Revenue from Operations: ₹4,277.16
  • Other Income: ₹60.93
  • Total Income: ₹4,338.09
  • Total Expenses: ₹3,708.60
  • Profit Before Tax: ₹629.49
  • Tax Expense: ₹169.85
  • Net Profit Before NCI: ₹459.64
  • Share of Non-Controlling Interests: ₹309.21
  • Net Profit Attributable to Owners: ₹150.43
  • Earnings Per Share (Basic & Diluted): ₹2.55
  • Paid-up Equity Share Capital: ₹590.04

Segment Performance (Q1 FY27):

  • Pharmaceuticals Segment: Revenue ₹1,025.90, PBT ₹(125.74)
  • Chemical Manufacturing Segment: Revenue ₹3,312.19, PBT ₹755.23

Management Change

Mr. Saahil Parikh (DIN: 00400079) informed the board he does not wish to be re-appointed as Whole-time Director/CEO upon completion of his term on August 10, 2026, citing personal and professional reasons.

The board appointed Mr. Saahil Parikh as Non-Executive, Non-Independent Director effective August 11, 2026, subject to shareholder approval. He will be liable to retire by rotation.

Revised Board Composition (Effective August 11, 2026)

  • Mr. R. K. P. Verma: Chairman, Independent Director
  • Ms. Dipti Shah: Independent Director
  • Mr. Vishal Jain: Independent Director
  • Mr. Prashant Godha: Non-Executive, Non-Independent Director
  • Mr. Saahil Parikh: Non-Executive, Non-Independent Director
  • Mr. Nilesh Jain: Executive, Whole-time Director

Committee Reconstituition

Stakeholders Relationship Committee:

  • Mr. R. K. P. Verma (Chairman)
  • Mr. Vishal Jain
  • Mr. Saahil Parikh

Risk Management Committee:

  • Mr. Saahil Parikh
  • Mr. Nilesh Jain
  • Mr. Sandeep Kadam (Sr. Manager Accounts/CFO)

Meeting Details

Board meeting held on August 7, 2026, at Kandivli, Mumbai, starting at 11:00 AM and concluding at 11:55 AM.

Auditor Information

N V C & Associates LLP (Firm Registration Number: 106971W/W101085) conducted limited review and issued unmodified reports dated August 7, 2026.